Supernus Pharmaceuticals (SUPN) Q4 2022 Earnings

8NovConfirmed
Q4 2021
Q2 2022
Q3 2022
Q4 2022
0.03
0.17
0.3
0.44

Details

Expected EPS
0.44
Actual EPS
0.03
Surprise EPS
-0.41
Surprise Percent
+93.18%

Description

Supernus Pharmaceuticals (SUPN) has reported earnings of 0.03 per share for Q4 2022.

0 Comments

Share your thoughts